Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADAGE: Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer
NCT02355379Phase 3Recruiting
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Jan 2015
- Primary completion
- Dec 2024
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of oxaliplatin, fluorouracil and capecitabine in colonic adenocarcinoma, sponsored by Fédération Francophone de Cancérologie Digestive. Started Jan 2015; status: recruiting.
02
Drugs
oxaliplatinfluorouracilcapecitabine
03
Conditions
colonic adenocarcinoma
Beyond the preview
Go deeper on NCT02355379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02355379.